{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:46:42Z","timestamp":1791269202881,"version":"4.1.0"},"reference-count":122,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.bbapap.2007.08.009","type":"journal-article","created":{"date-parts":[[2007,8,17]],"date-time":"2007-08-17T11:08:30Z","timestamp":1187348910000},"page":"203-212","source":"Crossref","is-referenced-by-count":78,"title":["Conserved herpesvirus protein kinases"],"prefix":"10.1016","volume":"1784","author":[{"given":"Edward","family":"Gershburg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph S.","family":"Pagano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbapap.2007.08.009_bib1","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/095632020601700302","article-title":"Antiviral chemistry & chemotherapy's current antiviral agents FactFile 2006 (1st edition)","volume":"17","author":"De Clercq","year":"2006","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.bbapap.2007.08.009_bib2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jcv.2004.02.009","article-title":"Antiviral drugs in current clinical use","volume":"30","author":"De Clercq","year":"2004","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.bbapap.2007.08.009_bib3","first-page":"2479","article-title":"Fields virology","author":"Pellett","year":"2007"},{"issue":"Pt 5","key":"10.1016\/j.bbapap.2007.08.009_bib4","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1099\/0022-1317-70-5-1151","article-title":"Alpha-, beta- and gammaherpesviruses encode a putative phosphotransferase","volume":"70","author":"Chee","year":"1989","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.bbapap.2007.08.009_bib5","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1128\/JVI.63.1.450-455.1989","article-title":"Identification of new protein kinase-related genes in three herpesviruses, herpes simplex virus, varicella-zoster virus, and Epstein\u2013Barr virus","volume":"63","author":"Smith","year":"1989","journal-title":"J. Virol."},{"key":"10.1016\/j.bbapap.2007.08.009_bib6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0042-6822(92)90161-H","article-title":"Serine protein kinase associated with varicella-zoster virus ORF 47","volume":"191","author":"Ng","year":"1992","journal-title":"Virology"},{"key":"10.1016\/j.bbapap.2007.08.009_bib7","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1128\/JVI.74.7.3093-3104.2000","article-title":"A protein kinase activity associated with Epstein\u2013Barr virus BGLF4 phosphorylates the viral early antigen EA-D in vitro","volume":"74","author":"Chen","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.bbapap.2007.08.009_bib8","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1128\/JVI.76.3.998-1003.2002","article-title":"Phosphorylation of the Epstein\u2013Barr virus (EBV) DNA polymerase processivity factor EA-D by the EBV-encoded protein kinase and effects of the l-riboside benzimidazole 1263W94","volume":"76","author":"Gershburg","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.bbapap.2007.08.009_bib9","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/358160a0","article-title":"Human cytomegalovirus UL97 open reading frame encodes a protein that phosphorylates the antiviral nucleoside analogue ganciclovir","volume":"358","author":"Littler","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.bbapap.2007.08.009_bib10","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/358162a0","article-title":"A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells","volume":"358","author":"Sullivan","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.bbapap.2007.08.009_bib11","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1128\/JVI.71.1.405-411.1997","article-title":"The human cytomegalovirus UL97 protein is a protein kinase that autophosphorylates on serines and threonines","volume":"71","author":"He","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.bbapap.2007.08.009_bib12","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1128\/JVI.73.4.3284-3291.1999","article-title":"The U69 gene of human herpesvirus 6 encodes a protein kinase which can confer ganciclovir sensitivity to baculoviruses","volume":"73","author":"Ansari","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.bbapap.2007.08.009_bib13","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1099\/0022-1317-81-4-1067","article-title":"Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) open reading frame 36 protein is a serine protein kinase","volume":"81","author":"Park","year":"2000","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.bbapap.2007.08.009_bib14","doi-asserted-by":"crossref","first-page":"5200","DOI":"10.1128\/JVI.66.9.5200-5209.1992","article-title":"Herpesviruses encode an unusual protein-serine\/threonine kinase which is nonessential for growth in cultured cells","volume":"66","author":"de Wind","year":"1992","journal-title":"J. Virol."},{"key":"10.1016\/j.bbapap.2007.08.009_bib15","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1099\/0022-1317-74-3-387","article-title":"A mutant of herpes simplex virus type 1 in which the UL13 protein kinase gene is disrupted","volume":"74","author":"Coulter","year":"1993","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.bbapap.2007.08.009_bib16","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.virol.2005.07.010","article-title":"The role of protein kinase activity expressed by the UL13 gene of herpes simplex virus 1: the activity is not essential for optimal expression of UL41 and ICP0","volume":"341","author":"Tanaka","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.bbapap.2007.08.009_bib17","doi-asserted-by":"crossref","first-page":"6701","DOI":"10.1073\/pnas.90.14.6701","article-title":"Processing of the herpes simplex virus regulatory protein alpha 22 mediated by the UL13 protein kinase determines the accumulation of a subset of alpha and gamma mRNAs and proteins in infected cells","volume":"90","author":"Purves","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbapap.2007.08.009_bib18","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1128\/JVI.80.3.1476-1486.2006","article-title":"Herpes simplex virus 1-encoded protein kinase UL13 phosphorylates viral Us3 protein kinase and regulates nuclear localization of viral envelopment factors UL34 and UL31","volume":"80","author":"Kato","year":"2006","journal-title":"J. Virol."},{"issue":"Pt 7","key":"10.1016\/j.bbapap.2007.08.009_bib19","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1099\/0022-1317-76-7-1851","article-title":"The US3-encoded protein kinase from pseudorabies virus affects egress of virions from the nucleus","volume":"76","author":"Wagenaar","year":"1995","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.bbapap.2007.08.009_bib20","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1099\/0022-1317-82-10-2363","article-title":"Effect of the pseudorabies virus US3 protein on nuclear membrane localization of the UL34 protein and virus egress from the nucleus","volume":"82","author":"Klupp","year":"2001","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.bbapap.2007.08.009_bib21","doi-asserted-by":"crossref","first-page":"7108","DOI":"10.1128\/JVI.72.9.7108-7114.1998","article-title":"Phosphorylation of structural components promotes dissociation of the herpes simplex virus type 1 tegument","volume":"72","author":"Morrison","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.bbapap.2007.08.009_bib22","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1006\/viro.1997.8653","article-title":"Purification and characterization of the protein kinase encoded by the UL13 gene of herpes simplex virus type 2","volume":"235","author":"Daikoku","year":"1997","journal-title":"Virology"},{"key":"10.1016\/j.bbapap.2007.08.009_bib23","doi-asserted-by":"crossref","first-page":"8854","DOI":"10.1128\/JVI.75.18.8854-8858.2001","article-title":"Varicella-zoster virus ORF47 protein serine kinase: characterization of a cloned, biologically active phosphotransferase and two viral substrates, ORF62 and ORF63","volume":"75","author":"Kenyon","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.bbapap.2007.08.009_bib24","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1128\/JVI.74.5.2265-2277.2000","article-title":"Nuclear accumulation of IE62, the varicella-zoster virus (VZV) major transcriptional regulatory protein, is inhibited by phosphorylation mediated by the VZV open reading frame 66 protein kinase","volume":"74","author":"Kinchington","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.bbapap.2007.08.009_bib25","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1128\/JVI.68.3.1350-1359.1994","article-title":"Phosphorylation of varicella-zoster virus open reading frame (ORF) 62 regulatory product by viral ORF 47-associated protein kinase","volume":"68","author":"Ng","year":"1994","journal-title":"J. Virol."},{"key":"10.1016\/j.bbapap.2007.08.009_bib26","doi-asserted-by":"crossref","first-page":"10980","DOI":"10.1128\/JVI.76.21.10980-10993.2002","article-title":"Phosphorylation by the varicella-zoster virus ORF47 protein serine kinase determines whether endocytosed viral gE traffics to the trans-Golgi network or recycles to the cell membrane","volume":"76","author":"Kenyon","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.bbapap.2007.08.009_bib27","first-page":"71","article-title":"Interactions among structural proteins of varicella zoster virus","author":"Spengler","year":"2001","journal-title":"Arch. Virol., Suppl."},{"key":"10.1016\/j.bbapap.2007.08.009_bib28","doi-asserted-by":"crossref","first-page":"8083","DOI":"10.1128\/JVI.72.10.8083-8088.1998","article-title":"Varicella-zoster virus (VZV) ORF32 encodes a phosphoprotein that is posttranslationally modified by the VZV ORF47 protein kinase","volume":"72","author":"Reddy","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.bbapap.2007.08.009_bib29","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1006\/viro.2002.1556","article-title":"The requirement of varicella zoster virus glycoprotein E (gE) for viral replication and effects of glycoprotein I on gE in melanoma cells","volume":"304","author":"Mo","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.bbapap.2007.08.009_bib30","doi-asserted-by":"crossref","first-page":"7367","DOI":"10.1128\/JVI.69.11.7367-7370.1995","article-title":"The varicella-zoster virus (VZV) open reading frame 47 (ORF47) protein kinase is dispensable for viral replication and is not required for phosphorylation of ORF63 protein, the VZV homolog of herpes simplex virus ICP22","volume":"69","author":"Heineman","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.bbapap.2007.08.009_bib31","doi-asserted-by":"crossref","first-page":"11969","DOI":"10.1073\/pnas.95.20.11969","article-title":"The ORF47 and ORF66 putative protein kinases of varicella-zoster virus determine tropism for human T cells and skin in the SCID-hu mouse","volume":"95","author":"Moffat","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbapap.2007.08.009_bib32","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.virol.2005.04.024","article-title":"Varicella-zoster virus open reading frame 47 (ORF47) protein is critical for virus replication in dendritic cells and for spread to other cells","volume":"337","author":"Hu","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.bbapap.2007.08.009_bib33","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.cellsig.2006.07.003","article-title":"Varicella-zoster virus requires a functional PI3K\/Akt\/GSK-3alpha\/beta signaling cascade for efficient replication","volume":"19","author":"Rahaus","year":"2007","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bbapap.2007.08.009_bib34","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1128\/AAC.40.4.920","article-title":"Analysis of phosphorylation pathways of antiherpesvirus nucleosides by varicella-zoster virus-specific enzymes","volume":"40","author":"Koyano","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbapap.2007.08.009_bib35","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0166-3542(99)00079-0","article-title":"Susceptibility of protein kinase (ORF47)-deficient varicella-zoster virus strains to anti-herpesvirus nucleosides","volume":"45","author":"Suzutani","year":"2000","journal-title":"Antivir. Res."},{"key":"10.1016\/j.bbapap.2007.08.009_bib36","doi-asserted-by":"crossref","first-page":"6340","DOI":"10.1128\/JVI.70.9.6340-6346.1996","article-title":"The UL97 gene product of human cytomegalovirus is an early\u2013late protein with a nuclear localization but is not a nucleoside kinase","volume":"70","author":"Michel","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.bbapap.2007.08.009_bib37","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1006\/viro.1997.8523","article-title":"The human cytomegalovirus UL97 protein is phosphorylated and a component of virions","volume":"231","author":"van Zeijl","year":"1997","journal-title":"Virology"},{"key":"10.1016\/j.bbapap.2007.08.009_bib38","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s007050050370","article-title":"Characterization of the human cytomegalovirus UL97 gene product as a virion-associated protein kinase","volume":"143","author":"Wolf","year":"1998","journal-title":"Arch. Virol."},{"key":"10.1016\/j.bbapap.2007.08.009_bib39","doi-asserted-by":"crossref","first-page":"5663","DOI":"10.1128\/JVI.73.7.5663-5670.1999","article-title":"A recombinant human cytomegalovirus with a large deletion in UL97 has a severe replication deficiency","volume":"73","author":"Prichard","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.bbapap.2007.08.009_bib40","doi-asserted-by":"crossref","first-page":"7044","DOI":"10.1021\/jm060696s","article-title":"Analysis of the structure-activity relationship of four herpesviral UL97 subfamily protein kinases reveals partial but not full functional conservation","volume":"49","author":"Romaker","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbapap.2007.08.009_bib41","doi-asserted-by":"crossref","first-page":"7720","DOI":"10.1128\/JVI.77.14.7720-7727.2003","article-title":"The human cytomegalovirus UL44 protein is a substrate for the UL97 protein kinase","volume":"77","author":"Krosky","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.bbapap.2007.08.009_bib42","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0042-6822(03)00147-8","article-title":"The protein kinase pUL97 of human cytomegalovirus interacts with and phosphorylates the DNA polymerase processivity factor pUL44","volume":"311","author":"Marschall","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.bbapap.2007.08.009_bib43","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1073\/pnas.98.4.1895","article-title":"Distinct and separate roles for herpesvirus-conserved UL97 kinase in cytomegalovirus DNA synthesis and encapsidation","volume":"98","author":"Wolf","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbapap.2007.08.009_bib44","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.virol.2004.03.015","article-title":"Phosphorylation of the RNA polymerase II carboxyl-terminal domain in human cytomegalovirus-infected cells and in vitro by the viral UL97 protein kinase","volume":"324","author":"Baek","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.bbapap.2007.08.009_bib45","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1128\/JVI.77.4.2359-2368.2003","article-title":"Conserved protein kinases encoded by herpesviruses and cellular protein kinase cdc2 target the same phosphorylation site in eukaryotic elongation factor 1delta","volume":"77","author":"Kawaguchi","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.bbapap.2007.08.009_bib46","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1128\/JVI.77.2.905-914.2003","article-title":"The human cytomegalovirus UL97 protein kinase, an antiviral drug target, is required at the stage of nuclear egress","volume":"77","author":"Krosky","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.bbapap.2007.08.009_bib47","doi-asserted-by":"crossref","first-page":"33357","DOI":"10.1074\/jbc.M502672200","article-title":"Cellular p32 recruits cytomegalovirus kinase pUL97 to redistribute the nuclear lamina","volume":"280","author":"Marschall","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2007.08.009_bib48","unstructured":"W.T. Seaman, E. Holley-Guthrie, E. Gershburg, S.J. Dickerson, H.-J. Delecluse, J.S. Pagano and S.C. Kenney, BMRF1 transcriptional function, but not phosphorylation by the BGLF4-encoded protein kinase, is important for Epstein\u2013Barr virus replication, submitted for publication."},{"key":"10.1016\/j.bbapap.2007.08.009_bib49","doi-asserted-by":"crossref","first-page":"15494","DOI":"10.1128\/JVI.79.24.15494-15502.2005","article-title":"Human cytomegalovirus UL97 Kinase is required for the normal intranuclear distribution of pp65 and virion morphogenesis","volume":"79","author":"Prichard","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.bbapap.2007.08.009_bib50","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.virol.2006.05.037","article-title":"Structural changes in human cytomegalovirus cytoplasmic assembly sites in the absence of UL97 kinase activity","volume":"354","author":"Azzeh","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.bbapap.2007.08.009_bib51","doi-asserted-by":"crossref","first-page":"11943","DOI":"10.1128\/JVI.76.23.11943-11952.2002","article-title":"Relationship between autophosphorylation and phosphorylation of exogenous substrates by the human cytomegalovirus UL97 protein kinase","volume":"76","author":"Baek","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.bbapap.2007.08.009_bib52","doi-asserted-by":"crossref","first-page":"29593","DOI":"10.1074\/jbc.M202312200","article-title":"Specific phosphorylation of exogenous protein and peptide substrates by the human cytomegalovirus UL97 protein kinase. Importance of the P+5 position","volume":"277","author":"Baek","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2007.08.009_bib53","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1128\/AAC.43.8.1941","article-title":"Acyclovir is phosphorylated by the human cytomegalovirus UL97 protein","volume":"43","author":"Talarico","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbapap.2007.08.009_bib54","doi-asserted-by":"crossref","first-page":"8898","DOI":"10.1128\/JVI.73.10.8898-8901.1999","article-title":"Amino acids of conserved kinase motifs of cytomegalovirus protein UL97 are essential for autophosphorylation","volume":"73","author":"Michel","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.bbapap.2007.08.009_bib55","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1006\/viro.1995.1228","article-title":"The DNA sequence of human herpesvirus-6: structure, coding content, and genome evolution","volume":"209","author":"Gompels","year":"1995","journal-title":"Virology"},{"key":"10.1016\/j.bbapap.2007.08.009_bib56","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1124\/mol.62.3.714","article-title":"Role of the human herpesvirus 6 U69-encoded kinase in the phosphorylation of ganciclovir","volume":"62","author":"De Bolle","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbapap.2007.08.009_bib57","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1099\/0022-1317-82-11-2767","article-title":"Selection of the same mutation in the U69 protein kinase gene of human herpesvirus-6 after prolonged exposure to ganciclovir in vitro and in vivo","volume":"82","author":"Manichanh","year":"2001","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.bbapap.2007.08.009_bib58","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/jmv.10510","article-title":"Mapping ganciclovir resistance in the human herpesvirus-6 U69 protein kinase","volume":"71","author":"Safronetz","year":"2003","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.bbapap.2007.08.009_bib59","doi-asserted-by":"crossref","first-page":"12140","DOI":"10.1128\/JVI.78.22.12140-12146.2004","article-title":"Expression and localization of the Epstein\u2013Barr virus-encoded protein kinase","volume":"78","author":"Gershburg","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.bbapap.2007.08.009_bib60","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1099\/vir.0.81313-0","article-title":"Detection of Epstein\u2013Barr virus BGLF4 protein kinase in virus replication compartments and virus particles","volume":"86","author":"Wang","year":"2005","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.bbapap.2007.08.009_bib61","doi-asserted-by":"crossref","first-page":"5407","DOI":"10.1128\/JVI.02398-06","article-title":"Epstein\u2013Barr virus-encoded protein kinase (BGLF4) is involved in production of infectious virus","volume":"81","author":"Gershburg","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.bbapap.2007.08.009_bib62","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1128\/JVI.79.6.3713-3727.2005","article-title":"Characterization and intracellular localization of the Epstein\u2013Barr virus protein BFLF2: interactions with BFRF1 and with the nuclear lamina","volume":"79","author":"Gonnella","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.bbapap.2007.08.009_bib63","doi-asserted-by":"crossref","first-page":"5166","DOI":"10.1128\/JVI.00120-07","article-title":"EBV BGLF4 kinase induces premature chromosome condensation through activation of condensin and topoisomerase II","volume":"81","author":"Lee","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.bbapap.2007.08.009_bib64","doi-asserted-by":"crossref","first-page":"10064","DOI":"10.1128\/JVI.00678-06","article-title":"Phosphorylation of MCM4 at sites inactivating DNA helicase activity of the MCM4-MCM6-MCM7 complex during Epstein\u2013Barr virus productive replication","volume":"80","author":"Kudoh","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.bbapap.2007.08.009_bib65","doi-asserted-by":"crossref","first-page":"5125","DOI":"10.1128\/JVI.02674-05","article-title":"Epstein\u2013Barr virus protein kinase BGLF4 is a virion tegument protein that dissociates from virions in a phosphorylation-dependent process and phosphorylates the viral immediate-early protein BZLF1","volume":"80","author":"Asai","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.bbapap.2007.08.009_bib66","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1099\/vir.0.19454-0","article-title":"Identification of protein kinases responsible for phosphorylation of Epstein\u2013Barr virus nuclear antigen leader protein at serine-35, which regulates its coactivator function","volume":"84","author":"Kato","year":"2003","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.bbapap.2007.08.009_bib67","doi-asserted-by":"crossref","first-page":"5880","DOI":"10.1128\/JVI.79.9.5880-5885.2005","article-title":"Hyperphosphorylation of EBNA2 by Epstein\u2013Barr virus protein kinase suppresses transactivation of the LMP1 promoter","volume":"79","author":"Yue","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.bbapap.2007.08.009_bib68","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1128\/AAC.48.5.1900-1903.2004","article-title":"Effects of maribavir and selected indolocarbazoles on Epstein\u2013Barr virus protein kinase BGLF4 and on viral lytic replication","volume":"48","author":"Gershburg","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbapap.2007.08.009_bib69","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1099\/0022-1317-82-6-1457","article-title":"Epstein\u2013Barr virus-encoded protein kinase BGLF4 mediates hyperphosphorylation of cellular elongation factor 1delta (EF-1delta): EF-1delta is universally modified by conserved protein kinases of herpesviruses in mammalian cells","volume":"82","author":"Kato","year":"2001","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.bbapap.2007.08.009_bib70","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1128\/JVI.57.3.1105-1112.1986","article-title":"Characterization of an Epstein\u2013Barr virus-induced thymidine kinase","volume":"57","author":"de Turenne-Tessier","year":"1986","journal-title":"J. Virol."},{"key":"10.1016\/j.bbapap.2007.08.009_bib71","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1002\/j.1460-2075.1986.tb04450.x","article-title":"Identification of an Epstein\u2013Barr virus-coded thymidine kinase","volume":"5","author":"Littler","year":"1986","journal-title":"EMBO. J."},{"key":"10.1016\/j.bbapap.2007.08.009_bib72","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000149213","article-title":"Synthesis of thymidine kinase (TK) in Epstein\u2013Barr virus-superinfected Raji TK-negative cells","volume":"15","author":"Roubal","year":"1981","journal-title":"Intervirology"},{"key":"10.1016\/j.bbapap.2007.08.009_bib73","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1128\/AAC.45.7.2082-2091.2001","article-title":"Induction of Epstein\u2013Barr virus kinases to sensitize tumor cells to nucleoside analogues","volume":"45","author":"Moore","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbapap.2007.08.009_bib74","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1128\/AAC.42.11.2923","article-title":"The Epstein\u2013Barr virus thymidine kinase does not phosphorylate ganciclovir or acyclovir and demonstrates a narrow substrate specificity compared to the herpes simplex virus type 1 thymidine kinase","volume":"42","author":"Gustafson","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbapap.2007.08.009_bib75","doi-asserted-by":"crossref","first-page":"7037","DOI":"10.1128\/JVI.00553-06","article-title":"Genetic organization and hypoxic activation of the Kaposi's sarcoma-associated herpesvirus ORF34-37 gene cluster","volume":"80","author":"Haque","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.bbapap.2007.08.009_bib76","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1128\/JVI.75.2.891-902.2001","article-title":"Kaposi's sarcoma-associated herpesvirus latent and lytic gene expression as revealed by DNA arrays","volume":"75","author":"Jenner","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.bbapap.2007.08.009_bib77","doi-asserted-by":"crossref","first-page":"4843","DOI":"10.1128\/JVI.75.10.4843-4853.2001","article-title":"Transcription program of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus)","volume":"75","author":"Paulose-Murphy","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.bbapap.2007.08.009_bib78","doi-asserted-by":"crossref","first-page":"13637","DOI":"10.1128\/JVI.78.24.13637-13652.2004","article-title":"Dissection of the Kaposi's sarcoma-associated herpesvirus gene expression program by using the viral DNA replication inhibitor cidofovir","volume":"78","author":"Lu","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.bbapap.2007.08.009_bib79","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1128\/JVI.01473-06","article-title":"Kaposi's sarcoma-associated herpesvirus-encoded protein kinase and its interaction with K-bZIP","volume":"81","author":"Izumiya","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.bbapap.2007.08.009_bib80","doi-asserted-by":"crossref","first-page":"38325","DOI":"10.1074\/jbc.M400964200","article-title":"ORF36 protein kinase of Kaposi's sarcoma herpesvirus activates the c-Jun N-terminal kinase signaling pathway","volume":"279","author":"Hamza","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2007.08.009_bib81","doi-asserted-by":"crossref","first-page":"9912","DOI":"10.1128\/JVI.79.15.9912-9925.2005","article-title":"Kaposi's sarcoma-associated herpesvirus K-bZIP represses gene transcription via SUMO modification","volume":"79","author":"Izumiya","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.bbapap.2007.08.009_bib82","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1128\/JVI.75.5.2388-2399.2001","article-title":"Epstein\u2013Barr virus immediate-early protein BZLF1 is SUMO-1 modified and disrupts promyelocytic leukemia bodies","volume":"75","author":"Adamson","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.bbapap.2007.08.009_bib83","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/0042-6822(92)90553-2","article-title":"Phosphorylation of the Epstein\u2013Barr virus BZLF1 immediate-early gene product ZEBRA","volume":"188","author":"Daibata","year":"1992","journal-title":"Virology"},{"key":"10.1016\/j.bbapap.2007.08.009_bib84","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1074\/jbc.M506076200","article-title":"Identification of constitutive phosphorylation sites on the Epstein\u2013Barr virus ZEBRA protein","volume":"281","author":"El-Guindy","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2007.08.009_bib85","doi-asserted-by":"crossref","first-page":"10115","DOI":"10.1073\/pnas.90.21.10115","article-title":"Serine-173 of the Epstein\u2013Barr virus ZEBRA protein is required for DNA binding and is a target for casein kinase II phosphorylation","volume":"90","author":"Kolman","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbapap.2007.08.009_bib86","doi-asserted-by":"crossref","first-page":"4786","DOI":"10.1128\/JVI.73.6.4786-4793.1999","article-title":"Human herpesvirus 8-encoded thymidine kinase and phosphotransferase homologues confer sensitivity to ganciclovir","volume":"73","author":"Cannon","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.bbapap.2007.08.009_bib87","doi-asserted-by":"crossref","first-page":"4456","DOI":"10.1128\/JVI.73.5.4456-4460.1999","article-title":"Cellular elongation factor 1delta is modified in cells infected with representative alpha-, beta-, or gammaherpesviruses","volume":"73","author":"Kawaguchi","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.bbapap.2007.08.009_bib88","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1128\/JVI.72.3.1731-1736.1998","article-title":"Eukaryotic elongation factor 1delta is hyperphosphorylated by the protein kinase encoded by the U(L)13 gene of herpes simplex virus 1","volume":"72","author":"Kawaguchi","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.bbapap.2007.08.009_bib89","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/rmv.402","article-title":"Protein kinases conserved in herpesviruses potentially share a function mimicking the cellular protein kinase cdc2","volume":"13","author":"Kawaguchi","year":"2003","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.bbapap.2007.08.009_bib90","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1006\/viro.1996.0609","article-title":"Partial substitution of the functions of the herpes simplex virus 1 U(L)13 gene by the human cytomegalovirus U(L)97 gene","volume":"225","author":"Ng","year":"1996","journal-title":"Virology"},{"key":"10.1016\/j.bbapap.2007.08.009_bib91","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1099\/0022-1317-83-5-1013","article-title":"Direct targeting of human cytomegalovirus protein kinase pUL97 by kinase inhibitors is a novel principle for antiviral therapy","volume":"83","author":"Marschall","year":"2002","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.bbapap.2007.08.009_bib92","doi-asserted-by":"crossref","first-page":"8423","DOI":"10.1128\/JVI.68.12.8423-8427.1994","article-title":"Human cytomegalovirus UL97 kinase confers ganciclovir susceptibility to recombinant vaccinia virus","volume":"68","author":"Metzger","year":"1994","journal-title":"J. Virol."},{"key":"10.1016\/j.bbapap.2007.08.009_bib93","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1128\/JVI.78.4.1893-1902.2004","article-title":"Lytic induction therapy for Epstein\u2013Barr virus-positive B-cell lymphomas","volume":"78","author":"Feng","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.bbapap.2007.08.009_bib94","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0163-7258(99)00004-2","article-title":"Viral and host-cell protein kinases: enticing antiviral targets and relevance of nucleoside, and viral thymidine, kinases","volume":"82","author":"Shugar","year":"1999","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbapap.2007.08.009_bib95","doi-asserted-by":"crossref","first-page":"A43","DOI":"10.1016\/0166-3542(96)80312-3","article-title":"Benzimidazoles for the treatment of human cytomegalovirus","volume":"30","author":"Koszalka","year":"1996","journal-title":"Antivir. Res."},{"key":"10.1016\/j.bbapap.2007.08.009_bib96","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1080\/15257779908041486","article-title":"Studies designed to increase the stability and antiviral activity (HCMV) of the active benzimidazole nucleoside, TCRB","volume":"18","author":"Townsend","year":"1999","journal-title":"Nucleosides Nucleotides"},{"key":"10.1016\/j.bbapap.2007.08.009_bib97","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1128\/AAC.46.8.2365-2372.2002","article-title":"Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole l-riboside with a unique mode of action","volume":"46","author":"Biron","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbapap.2007.08.009_bib98","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1128\/AAC.47.7.2186-2192.2003","article-title":"In vitro activities of benzimidazole d- and l-ribonucleosides against herpesviruses","volume":"47","author":"Williams","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbapap.2007.08.009_bib99","doi-asserted-by":"crossref","first-page":"7271","DOI":"10.1128\/JVI.73.9.7271-7277.1999","article-title":"Inhibition of Epstein\u2013Barr virus replication by a benzimidazole L-riboside: novel antiviral mechanism of 5, 6-dichloro-2-(isopropylamino)-1-beta-L-ribofuranosyl-1H-benzimidazole","volume":"73","author":"Zacny","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.bbapap.2007.08.009_bib100","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1128\/CDLI.8.6.1279-1281.2001","article-title":"Inhibition of ganciclovir-susceptible and -resistant human cytomegalovirus clinical isolates by the benzimidazole l-riboside 1263W94","volume":"8","author":"McSharry","year":"2001","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.bbapap.2007.08.009_bib101","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jcv.2006.07.010","article-title":"Maribavir sensitivity of cytomegalovirus isolates resistant to ganciclovir, cidofovir or foscarnet","volume":"37","author":"Drew","year":"2006","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.bbapap.2007.08.009_bib102","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1086\/518514","article-title":"Cytomegalovirus UL97 kinase mutations that confer maribavir resistance","volume":"196","author":"Chou","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.bbapap.2007.08.009_bib103","doi-asserted-by":"crossref","first-page":"7124","DOI":"10.1128\/JVI.78.13.7124-7130.2004","article-title":"Mutations in the human cytomegalovirus UL27 gene that confer resistance to maribavir","volume":"78","author":"Chou","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.bbapap.2007.08.009_bib104","doi-asserted-by":"crossref","first-page":"11499","DOI":"10.1128\/JVI.77.21.11499-11506.2003","article-title":"Resistance of human cytomegalovirus to the benzimidazole l-ribonucleoside maribavir maps to UL27","volume":"77","author":"Komazin","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.bbapap.2007.08.009_bib105","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1128\/AAC.46.9.2969-2976.2002","article-title":"Phase I dose escalation trial evaluating the pharmacokinetics, anti-human cytomegalovirus (HCMV) activity, and safety of 1263W94 in human immunodeficiency virus-infected men with asymptomatic HCMV shedding","volume":"46","author":"Lalezari","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbapap.2007.08.009_bib106","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1124\/dmd.105.009209","article-title":"N-methylpurine DNA glycosylase and 8-oxoguanine DNA glycosylase metabolize the antiviral nucleoside 2-bromo-5,6-dichloro-1-(beta-d-ribofuranosyl)benzimidazole","volume":"34","author":"Lorenzi","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bbapap.2007.08.009_bib107","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1128\/AAC.50.4.1130-1135.2006","article-title":"Maribavir pharmacokinetics and the effects of multiple-dose maribavir on cytochrome P450 (CYP) 1A2, CYP 2C9, CYP 2C19, CYP 2D6, CYP 3A, N-acetyltransferase-2, and xanthine oxidase activities in healthy adults","volume":"50","author":"Ma","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbapap.2007.08.009_bib108","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/0091270006296765","article-title":"Pharmacokinetics of maribavir, a novel oral anticytomegalovirus agent, in subjects with varying degrees of renal impairment","volume":"47","author":"Swan","year":"2007","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.bbapap.2007.08.009_bib109","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1128\/AAC.47.4.1334-1342.2003","article-title":"Phase I safety and pharmacokinetic trials of 1263W94, a novel oral anti-human cytomegalovirus agent, in healthy and human immunodeficiency virus-infected subjects","volume":"47","author":"Wang","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbapap.2007.08.009_bib110","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0968-0896(99)00032-2","article-title":"Indolocarbazoles: potent, selective inhibitors of human cytomegalovirus replication","volume":"7","author":"Slater","year":"1999","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bbapap.2007.08.009_bib111","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0166-3542(00)00118-2","article-title":"Indolocarbazoles exhibit strong antiviral activity against human cytomegalovirus and are potent inhibitors of the pUL97 protein kinase","volume":"48","author":"Zimmermann","year":"2000","journal-title":"Antivir. Res."},{"key":"10.1016\/j.bbapap.2007.08.009_bib112","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1099\/0022-1317-82-6-1439","article-title":"Inhibitors of human cytomegalovirus replication drastically reduce the activity of the viral protein kinase pUL97","volume":"82","author":"Marschall","year":"2001","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.bbapap.2007.08.009_bib113","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1128\/AAC.48.11.4154-4162.2004","article-title":"Novel chemical class of pUL97 protein kinase-specific inhibitors with strong anticytomegaloviral activity","volume":"48","author":"Herget","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbapap.2007.08.009_bib114","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1634\/theoncologist.8-4-303","article-title":"FDA drug approval summary: gefitinib (ZD1839) (Iressa) tablets","volume":"8","author":"Cohen","year":"2003","journal-title":"Oncologist"},{"key":"10.1016\/j.bbapap.2007.08.009_bib115","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1177\/1087057104270269","article-title":"Identification of inhibitors for a virally encoded protein kinase by 2 different screening systems: in vitro kinase assay and in-cell activity assay","volume":"10","author":"Mett","year":"2005","journal-title":"J. Biomol. Screen."},{"issue":"Pt 10","key":"10.1016\/j.bbapap.2007.08.009_bib116","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1099\/0022-1317-68-10-2699","article-title":"Identification of the herpes simplex virus protein kinase as the product of viral gene US3","volume":"68","author":"Frame","year":"1987","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.bbapap.2007.08.009_bib117","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1128\/JVI.63.8.3389-3398.1989","article-title":"Protein kinase activity associated with the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10)","volume":"63","author":"Chung","year":"1989","journal-title":"J. Virol."},{"key":"10.1016\/j.bbapap.2007.08.009_bib118","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1006\/viro.1997.8963","article-title":"UL13 protein kinase of herpes simplex virus 1 complexes with glycoprotein E and mediates the phosphorylation of the viral Fc receptor: glycoproteins E and I","volume":"241","author":"Ng","year":"1998","journal-title":"Virology"},{"key":"10.1016\/j.bbapap.2007.08.009_bib119","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1006\/viro.1997.8710","article-title":"The UL13 protein kinase and the infected cell type are determinants of posttranslational modification of ICP0","volume":"235","author":"Ogle","year":"1997","journal-title":"Virology"},{"key":"10.1016\/j.bbapap.2007.08.009_bib120","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.1128\/JVI.73.5.4305-4315.1999","article-title":"Functional anatomy of herpes simplex virus 1 overlapping genes encoding infected-cell protein 22 and US1.5 protein","volume":"73","author":"Ogle","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.bbapap.2007.08.009_bib121","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.1128\/JVI.73.5.3810-3817.1999","article-title":"A novel cellular protein, p60, interacting with both herpes simplex virus 1 regulatory proteins ICP22 and ICP0 is modified in a cell-type- specific manner and Is recruited to the nucleus after infection","volume":"73","author":"Bruni","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.bbapap.2007.08.009_bib122","doi-asserted-by":"crossref","first-page":"5593","DOI":"10.1128\/JVI.73.7.5593-5604.1999","article-title":"ICP22 and the UL13 protein kinase are both required for herpes simplex virus-induced modification of the large subunit of RNA polymerase II","volume":"73","author":"Long","year":"1999","journal-title":"J. Virol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S157096390700194X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S157096390700194X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,25]],"date-time":"2020-04-25T23:23:07Z","timestamp":1587856987000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S157096390700194X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":122,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S157096390700194X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbapap.2007.08.009","relation":{},"ISSN":["1570-9639"],"issn-type":[{"value":"1570-9639","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}